Table 2
Aggregation response, maximum velocity, and starting point of the aggregation curve for patients with thrombocytosis measured on the BCT using native PRP
| Patient | Age (years) | Sex | Antiplatelet treatment | Platelets/nl in native PRP | Aggregation response at end of aggregation (%) | Max. velocity (mE/sec) | Start of aggregation (mE) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADP | COL | ARA | ADP | COL | ARA | ADP | COL | ARA | |||||
| *des, desaggregation in %. | |||||||||||||
| ARA, arachidonic acid; ASA, acetylsalicylic acid; C, clopidogrel; COL, collagen; PRP, platelet rich plasma. | |||||||||||||
| 1 | 22 | F | ASA | 1535 | 83 | 75 | 82 | 55 | 53 | 64 | 3199 | 2846 | 2842 |
| 2 | 50 | M | – | 1471 | 90 | 82 | 91 | 71 | 57 | 78 | 3289 | 2900 | 2892 |
| 3 | 55 | M | – | 1487 | 81 | 79 | 80 | 47 | 46 | 62 | 3025 | 2720 | 2842 |
| 4 | 43 | M | ASA | 1258 | 31 (des: 50) | 81 | 1 | 56 | 36 | 2 | 3326 | 3079 | 2967 |
| 5 | 42 | F | – | 1490 | 4 (des: 29) | 81 | 88 | 25 | 54 | 65 | 2591 | 2400 | 2393 |
| 6 | 61 | M | – | 1534 | 78 | 75 | 83 | 50 | 49 | 70 | 3221 | 3052 | 3064 |
